Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences Inc. (NYSE: USNA) delivers science-backed nutritional supplements and personal care products through a global direct selling network. This page provides investors and industry observers with centralized access to official company announcements and market-moving developments.
Track USANA's latest press releases including quarterly financial results, product innovation announcements, executive leadership updates, and operational expansions. Our curated feed ensures timely access to filings, partnership disclosures, and strategic initiatives that shape the company's position in the health and wellness sector.
Key focus areas include regulatory milestones for nutritional products, market entry strategies in new regions, and advancements in manufacturing quality standards. All content is sourced directly from verified corporate communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of USANA's business trajectory, with updates organized chronologically for efficient research. Combine this resource with Stock Titan's financial analysis tools for comprehensive investment decision support.
USANA Health Sciences (NYSE:USNA) has scheduled its second quarter 2025 earnings release for Tuesday, July 22, 2025, after market close. The company will host a conference call to discuss the results on Wednesday, July 23, 2025, at 11:00 a.m. Eastern Time.
USANA develops and manufactures nutritional supplements, functional foods, and personal care products, operating through direct sales to Associates and Preferred Customers across 25 international markets. The company also maintains a 78.8% controlling stake in Hiya Health Products, a children's health and wellness company.
USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest is promoting personal freedom and self-care in July, coinciding with global freedom celebrations. Guest, author of "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony," outlines five key strategies for personal independence: releasing limiting beliefs, overcoming self-doubt, leaving toxic relationships, defeating loneliness, and avoiding burnout.
The initiative aligns with USANA's commitment to health and wellness, with the company operating in 25 countries since its founding in 1992. Guest's book proceeds support hunger relief, with each purchase providing 40 meals to children in need.
USANA (NYSE:USNA), a global cellular nutrition company, has announced significant enhancements to its Brand Partner program, set to fully launch in October 2025. The company has unveiled an updated compensation plan and brand story, developed in collaboration with over 50 experienced Brand Partners and industry experts.
Key improvements include a new 10% sales bonus on Brand Partners' and customers' first six months of purchases, three new Milestone Bonuses designed to create early success, and enhanced leadership bonuses focused on driving sustainable results. The company developed these changes after extensive data analysis and consultation with experts both within and outside the direct sales channel.
According to CEO Jim Brown, the enhanced program aims to attract new entrepreneurs while rewarding existing business builders for engagement and consistent growth. Chief Commercial Officer Brent Neidig emphasized that the new incentives are designed to be competitive in today's market while ensuring long-term business sustainability.
USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest shares key success strategies on Executive Coaching Day, drawing from his bestselling book "All the Right Reasons." Guest outlines four fundamental principles for professional and personal success:
- Growth Mindset: Developing abilities through effort and learning
- Power of Collaboration: Working together toward shared goals
- Vision: Maintaining clear direction and purpose
- Resilience: Adapting and recovering from setbacks
Guest illustrates these principles through personal stories, including how his parents rebuilt their lumber mill after a devastating fire. His book "All the Right Reasons" supports charitable causes, with each purchase providing 40 meals to hungry children.
USANA Health Sciences has achieved a significant recognition as its Celavive Postbiotic Rescue Serum was selected as a winner in the Good Housekeeping 2025 Beauty Awards. The announcement came on April 28, 2025, highlighting the company's innovation in skincare products.
The award-winning serum is designed as a daily calming treatment specifically formulated for stressed-out and blemish-prone skin. The product's key features include a lightweight formula enriched with microbiome-friendly postbiotics and soothing botanicals, aimed at visibly resetting and balancing skin appearance while enhancing moisture levels.
Chief Commercial Officer Brent Neidig credited the company's product and R&D teams for their dedication in developing the postbiotic line, emphasizing the significant effort invested in creating this award-winning skincare solution.
USANA Health Sciences (NYSE: USNA) reported Q1 2025 financial results with net sales of $250 million, up 10% year-over-year. The company saw mixed performance with net earnings declining 43% to $9.4 million and diluted EPS falling to $0.49 from $0.86.
Key metrics include Adjusted EBITDA of $30 million (-10% YoY) and Direct Selling Active Customers of 459,000. The company's Hiya division showed strong performance with 224,000 Active Monthly Subscribers and $37 million in net sales.
USANA reiterated its fiscal year 2025 outlook, projecting consolidated net sales of $920 million to $1.0 billion and adjusted diluted EPS of $2.35 to $3.00. The company repurchased 399,000 shares for $12 million during Q1, with $49 million remaining under current authorization.
Management noted potential challenges from international trade uncertainties and tariffs, particularly regarding raw materials trade between the US and China, though these impacts are not reflected in current guidance.